214 related articles for article (PubMed ID: 29042073)
1. Functional network dysconnectivity as a biomarker of treatment resistance in schizophrenia.
McNabb CB; Tait RJ; McIlwain ME; Anderson VM; Suckling J; Kydd RR; Russell BR
Schizophr Res; 2018 May; 195():160-167. PubMed ID: 29042073
[TBL] [Abstract][Full Text] [Related]
2. Increased sensorimotor network connectivity associated with clozapine eligibility in people with schizophrenia.
McNabb CB; Sundram F; Soosay I; Kydd RR; Russell BR
Psychiatry Res Neuroimaging; 2018 May; 275():36-42. PubMed ID: 29650266
[TBL] [Abstract][Full Text] [Related]
3. Differences in white matter connectivity between treatment-resistant and treatment-responsive subtypes of schizophrenia.
McNabb CB; Kydd R; Sundram F; Soosay I; Russell BR
Psychiatry Res Neuroimaging; 2018 Dec; 282():47-54. PubMed ID: 30412902
[TBL] [Abstract][Full Text] [Related]
4. Extensive gray matter volume reduction in treatment-resistant schizophrenia.
Anderson VM; Goldstein ME; Kydd RR; Russell BR
Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781
[TBL] [Abstract][Full Text] [Related]
5. Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [
Kim S; Jung WH; Howes OD; Veronese M; Turkheimer FE; Lee YS; Lee JS; Kim E; Kwon JS
Psychol Med; 2019 Nov; 49(15):2533-2542. PubMed ID: 30460891
[TBL] [Abstract][Full Text] [Related]
6. Risk and resilience brain networks in treatment-resistant schizophrenia.
Ganella EP; Seguin C; Bartholomeusz CF; Whittle S; Bousman C; Wannan CMJ; Di Biase MA; Phassouliotis C; Everall I; Pantelis C; Zalesky A
Schizophr Res; 2018 Mar; 193():284-292. PubMed ID: 28735641
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of fronto-subcortical pathways in schizophrenia and the differential impacts of antipsychotic treatment: a DTI-based tractography study.
Leroux E; Vandevelde A; Tréhout M; Dollfus S
Psychiatry Res Neuroimaging; 2018 Oct; 280():22-29. PubMed ID: 30145382
[TBL] [Abstract][Full Text] [Related]
8. Elevated intrinsic cortical curvature in treatment-resistant schizophrenia: Evidence of structural deformation in functional connectivity areas and comparison with alternate indices of structure.
Torres-Carmona E; Ueno F; Iwata Y; Nakajima S; Song J; Mar W; Abdolizadeh A; Agarwal SM; de Luca V; Remington G; Gerretsen P; Graff-Guerrero A
Schizophr Res; 2024 Jul; 269():103-113. PubMed ID: 38761434
[TBL] [Abstract][Full Text] [Related]
9. Effect of second-generation antipsychotics on brain network topology in first-episode schizophrenia: A longitudinal rs-fMRI study.
Wang LX; Guo F; Zhu YQ; Wang HN; Liu WM; Li C; Wang XR; Cui LB; Xi YB; Yin H
Schizophr Res; 2019 Jun; 208():160-166. PubMed ID: 30967317
[TBL] [Abstract][Full Text] [Related]
10. Resting-state functional connectivity in treatment response and resistance in schizophrenia: A systematic review.
Chan NK; Kim J; Shah P; Brown EE; Plitman E; Carravaggio F; Iwata Y; Gerretsen P; Graff-Guerrero A
Schizophr Res; 2019 Sep; 211():10-20. PubMed ID: 31331784
[TBL] [Abstract][Full Text] [Related]
11. Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications.
Pillinger T; Rogdaki M; McCutcheon RA; Hathway P; Egerton A; Howes OD
Psychopharmacology (Berl); 2019 Jul; 236(7):1985-1997. PubMed ID: 30820633
[TBL] [Abstract][Full Text] [Related]
12. Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia.
McQueen G; Lay A; Lally J; Gabay AS; Collier T; Lythgoe DJ; Barker GJ; Stone JM; McGuire P; MacCabe JH; Egerton A
Psychopharmacology (Berl); 2020 Feb; 237(2):443-451. PubMed ID: 31786651
[TBL] [Abstract][Full Text] [Related]
13. Mapping Thalamocortical Functional Connectivity in Chronic and Early Stages of Psychotic Disorders.
Woodward ND; Heckers S
Biol Psychiatry; 2016 Jun; 79(12):1016-25. PubMed ID: 26248537
[TBL] [Abstract][Full Text] [Related]
14. Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia.
Goldstein ME; Anderson VM; Pillai A; Kydd RR; Russell BR
Int J Neuropsychopharmacol; 2015 Jan; 18(6):. PubMed ID: 25603859
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [
Kim E; Howes OD; Veronese M; Beck K; Seo S; Park JW; Lee JS; Lee YS; Kwon JS
Neuropsychopharmacology; 2017 Mar; 42(4):941-950. PubMed ID: 27857125
[TBL] [Abstract][Full Text] [Related]
16. Linking resting-state networks and social cognition in schizophrenia and bipolar disorder.
Jimenez AM; Riedel P; Lee J; Reavis EA; Green MF
Hum Brain Mapp; 2019 Nov; 40(16):4703-4715. PubMed ID: 31322784
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotics Effects on Network-Level Reconfiguration of Cortical Morphometry in First-Episode Schizophrenia.
Jiang Y; Wang Y; Huang H; He H; Tang Y; Su W; Xu L; Wei Y; Zhang T; Hu H; Wang J; Yao D; Wang J; Luo C
Schizophr Bull; 2022 Jan; 48(1):231-240. PubMed ID: 34313782
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
[TBL] [Abstract][Full Text] [Related]
19. Schizophrenia and the brain's control network: aberrant within- and between-network connectivity of the frontoparietal network in schizophrenia.
Tu PC; Lee YC; Chen YS; Li CT; Su TP
Schizophr Res; 2013 Jul; 147(2-3):339-47. PubMed ID: 23706416
[TBL] [Abstract][Full Text] [Related]
20. Effect of Risperidone Monotherapy on Dynamic Functional Connectivity of Insular Subdivisions in Treatment-Naive, First-Episode Schizophrenia.
Duan X; Hu M; Huang X; Su C; Zong X; Dong X; He C; Xiao J; Li H; Tang J; Chen X; Chen H
Schizophr Bull; 2020 Apr; 46(3):650-660. PubMed ID: 31504959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
